The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients

por van den Bos, W., de Bruin, D. M., Jurhill, R. R., Savci-Heijink, C. D., Muller, B. G., Varkarakis, I. M., Skolarikos, A., Zondervan, P. J., Laguna-Pes, M. P., Wijkstra, H., de Reijke, T. M., de la Rosette, J. J. M. C. H.
Publicado 2015

The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol

por van den Bos, W, de Bruin, D M, Muller, B G, Varkarakis, I M, Karagiannis, A A, Zondervan, P J, Laguna Pes, M P, Veelo, D P, Savci Heijink, C D, Engelbrecht, M R W, Wijkstra, H, de Reijke, T M, de la Rosette, J J M C H
Publicado 2014

MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by...

por van den Bos, Willemien, de Bruin, D. M., van Randen, A., Engelbrecht, M. R. W., Postema, A. W., Muller, B. G., Varkarakis, I. M., Skolarikos, A., Savci-Heijink, C. D., Jurhill, R. R., Zondervan, P. J., Laguna Pes, M. P., Wijkstra, H., de Reijke, T. M., de la Rosette, J. J. M. C. H.
Publicado 2015

Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project

por Postema, A. W., De Reijke, T. M., Ukimura, O., Van den Bos, W., Azzouzi, A. R., Barret, E., Baumunk, D., Blana, A., Bossi, A., Brausi, M., Coleman, J. A., Crouzet, S., Dominguez-Escrig, J., Eggener, S., Ganzer, R., Ghai, S., Gill, I. S., Gupta, R. T., Henkel, T. O., Hohenfellner, M., Jones, J. S., Kahmann, F., Kastner, C., Köhrmann, K. U., Kovacs, G., Miano, R., van Moorselaar, R. J., Mottet, N., Osorio, L., Pieters, B. R., Polascik, T. J., Rastinehad, A. R., Salomon, G., Sanchez-Salas, R., Schostak, M., Sentker, L., Tay, K. J., Varkarakis, I. M., Villers, A., Walz, J., De la Rosette, J. J.
Publicado 2016